双相障碍中氯胺酮诱导解离状态的神经生理相关因素:真实临床环境下的启示
本研究纳入30例接受氯胺酮治疗的双相障碍抑郁住院患者,在输注期间进行脑电图记录并用CADSS评估主观效应。氯胺酮降低低频功率、增加γ振荡功率、平坦化功率谱斜率并增加高频熵,且迟发应答者脑电变化大于早期应答者。
要点
- 氯胺酮降低低频功率密度并增加γ振荡功率,同时平坦化功率谱斜率。
- 氯胺酮增加脑信号熵,尤其在高频段。
- 迟发应答者脑电变化大于早期应答者,提示治疗敏感性存在内表型差异。
核心结论
- 氯胺酮在双相障碍抑郁中引起可测量的急性神经生理变化,脑电生物标志物可能有助于评估其治疗机制。
研究设计与样本
- 研究纳入30例(女性12例)接受氯胺酮治疗的双相障碍抑郁住院患者,在一次输注期间进行脑电图记录,剂量范围为0.5至1 mg/kg,并用CADSS评估主观效应。
主要发现
- 氯胺酮降低低频频谱功率密度并增加γ振荡功率。
- 氯胺酮平坦化功率谱斜率,提示无标度动力学改变。
- 氯胺酮增加脑信号熵,尤其在高频段。
- 迟发应答者相比早期应答者表现出更大的脑电变化。
关键数值与推荐
- 一周内出现临床应答者归类为早期应答者,较晚应答者归类为迟发应答者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ketamine, a dissociative compound, shows promise in treating mood disorders, including treatment-resistant depression (TRD) and bipolar disorder (BD). Despite its therapeutic potential, the neurophysiological mechanisms underlying ketamine's effects are not fully understood. This study explored acute neurophysiological changes induced by subanesthetic doses of ketamine in BD patients with depression using electroencephalography (EEG) biomarkers. A cohort of 30 BD (F = 12) inpatients with TRD undergoing ketamine treatment was included in the study. EEG recordings were performed during one of the ketamine infusions with doses ranging from 0.5 to 1 mg/kg, and subjective effects were evaluated using the Clinician-Administered Dissociative States Scale (CADSS). Both rhythmic and arrhythmic features were extrapolated from the EEG signal. Patients who exhibited a clinical response to ketamine treatment within one week were classified as early responders (ER), whereas those who responded later were categorized as late responders (LR). Ketamine reduced low-frequency spectral power density while increasing gamma oscillatory power. Additionally, ketamine flattened the slope of the power spectra, indicating altered scale-free dynamics. Ketamine also increased brain signal entropy, particularly in high-frequency bands. Notably, LR exhibited greater EEG changes compared to ER, suggesting endophenotypic differences in treatment sensitivity. These findings provide valuable insights into the neurophysiological effects of ketamine in BD depression, highlighting the utility of EEG biomarkers for assessing ketamine's therapeutic mechanisms in real-world clinical settings. Understanding the neural correlates of ketamine response may contribute to personalized treatment approaches and improved management of mood disorders.
引用
- Agnorelli C, Cinti A, Barillà G, et al. Neurophysiological correlates of ketamine-induced dissociative state in bipolar disorder: insights from real-world clinical settings. Mol Psychiatry. 2025. PMID: 39809847. doi:10.1038/s41380-025-02889-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。